Sound View Wealth Advisors Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$374K Sell
4,665
-15
-0.3% -$1.24K 0.03% 311
2025
Q4
$399K Sell
4,680
-281
-6% -$23.1K 0.03% 306
2025
Q3
$386K Buy
4,961
+11
+0.2% +$859 0.03% 311
2025
Q2
$387K Buy
4,950
+36
+0.7% +$2.69K 0.03% 310
2025
Q1
$356K Buy
4,914
+223
+5% +$16K 0.03% 310
2024
Q4
$347K Sell
4,691
-336
-7% -$23.5K 0.03% 315
2024
Q3
$332K Buy
5,027
+912
+22% +$66.3K 0.03% 319
2024
Q2
$380K Hold
4,115
0.04% 268
2024
Q1
$393K Sell
4,115
-21
-0.5% -$1.76K 0.04% 269
2023
Q4
$315K Hold
4,136
0.03% 296
2023
Q3
$287K Buy
4,136
+276
+7% +$22.2K 0.04% 295
2023
Q2
$364K Sell
3,860
-291
-7% -$25.3K 0.05% 265
2023
Q1
$343K Buy
4,151
+15
+0.4% +$1.18K 0.05% 267
2022
Q4
$315K Buy
+4,136
New +$319K 0.03% 296
2022
Q3
Sell
-2,561
Closed -$244K 273
2022
Q2
$244K Buy
2,561
+415
+19% +$43K 0.05% 247
2022
Q1
$253K Buy
2,146
+2
+0.1% +$224 0.05% 259
2021
Q4
$278K Hold
2,144
0.05% 252
2021
Q3
$243K Hold
2,144
0.05% 259
2021
Q2
$222K Buy
+2,144
New +$202K 0.05% 266

Other funds holding EW

Sound View Wealth Advisors Group's EW Position: Q1 2026 in Review

Sound View Wealth Advisors Group reduced its Edwards Lifesciences (EW) stake by 0.32% in Q1 2026, selling an estimated $1.24K and leaving 4,665 shares worth $374K. The position accounts for 0.03% of the portfolio, ranked #311.

Sound View Wealth Advisors Group first reported a position in EW in Q2 2021 and has held it in 19 quarters since. The position peaked at $399K in Q4 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Sound View Wealth Advisors Group held 4,665 shares of Edwards Lifesciences worth $374K as of Q1 2026.
  • Sound View Wealth Advisors Group sold 15 Edwards Lifesciences shares in Q1 2026, an estimated $1.24K.
  • Edwards Lifesciences made up 0.03% of Sound View Wealth Advisors Group's portfolio in Q1 2026, its #311 holding.
  • Sound View Wealth Advisors Group first reported a position in Edwards Lifesciences in Q2 2021 and has held it in 19 quarters since.
  • Sound View Wealth Advisors Group's Edwards Lifesciences position peaked at $399K in Q4 2025.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Sound View Wealth Advisors Group's 13F filing for Q1 2026, filed 6 May 2026.